Clinical Trial Update: A Phase I/Ⅱ Clinical Trial for Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Ankylosing Spondylitis [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating Umbilical Cord Mesenchymal Stem Cells for the treatment of Ankylosing Spondylitis, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. | Conditions: Ankylosing Spondylitis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING